These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7843880)

  • 1. DNA technology and vaccines.
    Brown F
    Int J Technol Assess Health Care; 1994; 10(4):583-91. PubMed ID: 7843880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabies vaccine: traditional and novel approaches.
    Kieny MP; Desmettre P; Soulebot JP; Lathe R
    Prog Vet Microbiol Immunol; 1987; 3():73-111. PubMed ID: 3078836
    [No Abstract]   [Full Text] [Related]  

  • 3. Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep.
    Bouet-Cararo C; Contreras V; Fournier A; Jallet C; Guibert JM; Dubois E; Thiery R; Bréard E; Tordo N; Richardson J; Schwartz-Cornil I; Zientara S; Klonjkowski B
    Vaccine; 2011 Feb; 29(6):1304-10. PubMed ID: 21134446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivated Recombinant Rabies Viruses Displaying Canine Distemper Virus Glycoproteins Induce Protective Immunity against Both Pathogens.
    da Fontoura Budaszewski R; Hudacek A; Sawatsky B; Krämer B; Yin X; Schnell MJ; von Messling V
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs.
    Shuai L; Wang X; Wen Z; Ge J; Wang J; Zhao D; Bu Z
    Antiviral Res; 2017 Oct; 146():36-44. PubMed ID: 28822816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering of live rabies vaccines.
    Morimoto K; McGettigan JP; Foley HD; Hooper DC; Dietzschold B; Schnell MJ
    Vaccine; 2001 May; 19(25-26):3543-51. PubMed ID: 11348722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious vaccines.
    Ross DW
    Arch Pathol Lab Med; 1998 Jan; 122(1):100-1. PubMed ID: 9448028
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Am J Vet Res; 2003 Apr; 64(4):499-505. PubMed ID: 12693543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a candidate polyvalent live vaccine against human immunodeficiency, hepatitis B, and orthopox viruses.
    Shchelkunov SN; Nesterov AE; Ryazankin IA; Ignat'ev GM; Sandakhchiev LS
    Dokl Biochem Biophys; 2003; 390():180-3. PubMed ID: 12959074
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ.
    Barkhouse DA; Faber M; Hooper DC
    Virology; 2015 Jan; 474():174-80. PubMed ID: 25463615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a reverse genetics system for a human rabies virus vaccine strain employed in China.
    Huang Y; Tang Q; Nadin-Davis SA; Zhang S; Hooper CD; Ming P; Du J; Tao X; Hu R; Liang G
    Virus Res; 2010 Apr; 149(1):28-35. PubMed ID: 20080136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic strain modification of a live rabies virus vaccine widely used in Europe for wildlife oral vaccination.
    Cliquet F; Robardet E; Picard Meyer E
    Antiviral Res; 2013 Oct; 100(1):84-9. PubMed ID: 23899697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines.
    Franka R; Wu X; Jackson FR; Velasco-Villa A; Palmer DP; Henderson H; Hayat W; Green DB; Blanton JD; Greenberg L; Rupprecht CE
    Vaccine; 2009 Nov; 27(51):7149-55. PubMed ID: 19925945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health ethology of the fox and antirabies vaccine in the Italian experience].
    Balbo T
    Parassitologia; 1988; 30(1):13-7. PubMed ID: 3268766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN; Mundt W; Kistner O; Howard MK
    Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response in cattle after vaccination with inactivated and attenuated rabies vaccines.
    Rodrigues da Silva AC; Caporale GM; Gonçalves CA; Targueta MC; Comin F; Zanetti CR; Kotait I
    Rev Inst Med Trop Sao Paulo; 2000; 42(2):95-8. PubMed ID: 10810324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein from street rabies virus BD06 induces early and robust immune responses when expressed from a non-replicative adenovirus recombinant.
    Wang S; Sun C; Zhang S; Zhang X; Liu Y; Wang Y; Zhang F; Wu X; Hu R
    Arch Virol; 2015 Sep; 160(9):2315-23. PubMed ID: 26143474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy studies on a canarypox-rabies recombinant virus.
    Taylor J; Trimarchi C; Weinberg R; Languet B; Guillemin F; Desmettre P; Paoletti E
    Vaccine; 1991 Mar; 9(3):190-3. PubMed ID: 2042391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preexposure efficacy of a novel combination DNA and inactivated rabies virus vaccine.
    Biswas S; Reddy GS; Srinivasan VA; Rangarajan PN
    Hum Gene Ther; 2001 Oct; 12(15):1917-22. PubMed ID: 11589833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.